Tomocube Inc
KOSDAQ:475960
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13 660
62 700
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tomocube Inc
Tomocube Inc is a KR-based company operating in industry. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2024-11-07. TomoCube Inc is a Korea-based company primarily engaged in manufacturing and selling of imaging devices used in life science research and diagnostics. The Company’s holotomography (HT) technology uses light diffraction to obtain three-dimensional (3D) images of cells and tissues without dyeing or labeling. This technology can be used to reconstruct the refractive index (RI) distribution of cells in real time as a 3D image, which can be applied to cell therapy and organoid research, life science research and diagnostics.
Tomocube Inc is a KR-based company operating in industry. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2024-11-07. TomoCube Inc is a Korea-based company primarily engaged in manufacturing and selling of imaging devices used in life science research and diagnostics. The Company’s holotomography (HT) technology uses light diffraction to obtain three-dimensional (3D) images of cells and tissues without dyeing or labeling. This technology can be used to reconstruct the refractive index (RI) distribution of cells in real time as a 3D image, which can be applied to cell therapy and organoid research, life science research and diagnostics.